Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-29 | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY
(Director) |
S | Common Stock | D | 50000 | $41.16 - $41.16 | $2,057,890 |
| 2024-02-29 | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY
(Director) |
M | Common Stock | A | 50000 | $3.50 - $3.50 | $175,000 |
| 2024-02-20 | Cerevel Therapeutics Holdings, Inc. | EDELMAN JOSEPH
(Director) |
G | Common Stock | D | 170317 | $0.00 - $0.00 | $0 |
| 2024-02-07 | Cerevel Therapeutics Holdings, Inc. | Renger John
(Chief Scientific Officer) |
S | Common Stock | D | 2161 | $41.54 - $41.54 | $89,776 |
| 2024-02-07 | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY
(Director) |
S | Common Stock | D | 2506 | $41.54 - $41.54 | $104,109 |
| 2024-01-02 | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY
(Director) |
S | Common Stock | D | 50000 | $42.24 - $42.24 | $2,111,815 |
| 2024-01-02 | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY
(Director) |
M | Common Stock | A | 50000 | $3.50 - $3.50 | $175,000 |
| 2023-12-26 | Cerevel Therapeutics Holdings, Inc. | Sanchez Ramiro
(Chief Medical Officer) |
S | Common Stock | D | 10000 | $42.47 - $42.47 | $424,700 |
| 2023-12-26 | Cerevel Therapeutics Holdings, Inc. | Tregoning Kathleen
(See Remarks) |
M | Common Stock | A | 3150 | $10.05 - $10.05 | $31,657 |
| 2023-12-20 | Cerevel Therapeutics Holdings, Inc. | Bodenrader Mark
(See Remarks) |
S | Common Stock | D | 7889 | $41.42 - $41.42 | $326,787 |
| 2023-12-15 | Cerevel Therapeutics Holdings, Inc. | Sanchez Ramiro
(Chief Medical Officer) |
S | Common Stock | D | 7500 | $41.39 - $41.39 | $310,392 |
| 2023-12-15 | Cerevel Therapeutics Holdings, Inc. | Sanchez Ramiro
(Chief Medical Officer) |
M | Common Stock | A | 7500 | $9.88 - $9.88 | $74,100 |
| 2023-12-05 | Cerevel Therapeutics Holdings, Inc. | Akamine Scott
(Chief Legal Officer) |
S | Common Stock | D | 17500 | $35.00 - $41.37 | $676,200 |
| 2023-12-05 | Cerevel Therapeutics Holdings, Inc. | Akamine Scott
(Chief Legal Officer) |
M | Common Stock | A | 17500 | $13.17 - $13.17 | $230,475 |
| 2023-11-07 | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY
(Director) |
S | Common Stock | D | 27176 | $25.02 - $25.16 | $680,071 |
| 2023-11-07 | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY
(Director) |
M | Common Stock | A | 27176 | $3.50 - $3.50 | $95,116 |
| 2023-11-02 | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY
(Director) |
S | Common Stock | D | 100000 | $25.19 - $25.43 | $2,533,697 |
| 2023-11-02 | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY
(Director) |
M | Common Stock | A | 100000 | $3.50 - $3.50 | $349,999 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |